Merck, a leading science and technology company, today announced the presentation of detailed results from Cohort B of the ...

“Some of the rashes can be devastating and often ... graft because of bone decay caused by long-term use of steroids to treat lupus. She has had a double hip replacement and required physical ...

This unpredictable autoimmune disease presents unique challenges for people with it. This unpredictable autoimmune disease ...

Full results from the first phase 3 trial of UCB and Biogen's anti-CD40L antibody dapirolizumab pegol (DZP) in systemic lupus ...

Enpatoran Shows Promise in Treating Lupus Rash The oral TLR 7/8 inhibitor showed ... Immunosuppressants or Steroids First? The withdrawal of immunosuppressants proves noninferior to the withdrawal ...

Cohort B of the Phase 2 study indicates all doses of enpatoran were associated with higher BICLA response rates compared with placebo, though the ...

The etiology of these rashes can be divided into those that are specific to lupus and those that can ... are commonly used to treat SCLE. Steroids and cytotoxic agents may be used in severe ...

He lamented that steroids remain ... "No two lupus patients are alike. Some patients can have moderate to severe disease, which includes skin rashes and affects major organs," Lichauco said.

1 The rash is often exacerbated or triggered ... Typical treatments for chilblain lupus erythematosus include topical steroids, tacrolimus, or pimecrolimus; however, in more severe cases, oral ...

The malar rash may develop months or years before the onset of lupus. SCLE lesions are described as having ... leaving a small scar. Topical steroids reduce inflammation and can be applied either ...